Amarylle Van Doorn

Amarylle Van Doorn

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 August 2020 in Alimentary Pharmacology & Therapeutics
Verified
Journal Article
Open access
PDF file
ADAmarylle Van Doorn
Amarylle Van Doorn
BMBerrie Meijer
Berrie Meijer
CFChris M. A. Frampton
Chris M. A. Frampton
MBMurray L. Barclay
Murray L. Barclay
NBNanne De Boer
Nanne De Boer
Summary: Background: Since the start of the COVID‐19 pandemic, there have been many scientific reports regarding gastrointestinal manifestations. Several reports indicate the possibility of viral shedding via faeces and the possibility of faecal‐oral transmission.Aims: To critically assess the clinical relevance of testing stool samples and anal swabs and provide an overview of the potential faecal‐oral transmission of SARS‐CoV‐2.Methods: A systematic literature search with MeSH terms was performed, scrutinising the Embase database, Google scholar, MEDLINE database through PubMed and The Cochrane Library, including articles from December 2019 until July 7 2020. Data were subsequently analysed with descriptive statistics.Results: Ninety‐five studies were included in the qualitative analysis. 934/2149 (43%) patients tested positive for SARS‐CoV‐2 in stool samples or anal swabs, with positive test results up to 70 days after symptom onset. A meta‐analysis executed with studies of at least 10 patients revealed a pooled positive proportion of 51.8% (95% CI 43.8 ‐ 59.7%). Positive faecal samples of 282/443 patients (64%) remained positive for SARS‐CoV‐2 for a mean of 12.5 days, up to 33 days maximum, after respiratory samples became negative for SARS‐CoV‐2. Viable SARS‐CoV‐2 was found in 6/17 (35%) patients in whom this was specifically investigated.Conclusions: Viral shedding of SARS‐CoV‐2 in stool samples occurs in a substantial proportion of patients, making faecal‐oral transmission plausible. Furthermore, detection in stool samples or anal swabs can persist long after negative respiratory testing. Therefore, stool sample or anal swab testing should be (re)considered in relation to decisions for isolating or discharging a patient.

4 December 2023 in Challenges
Verified
Journal Article
Open access
PDF file
RKRemco Kort
Remco Kort
KAKoen Arts
Koen Arts
Josep M. BoquéJosep M. Boqué
Josep M. Boqué
Matty P. BergMatty P. Berg
Matty P. Berg
GCGabrielle Cepella
Gabrielle Cepella
PMPim Martens
Pim Martens
The First European Planetary Health Congress, held from 5 to 7 July 2023 at ARTIS in Amsterdam, represented a significant milestone in the global movement of Planetary Health. The event brought together 121 attendees from academia and the private sector dedicated to addressing the impact of human disruptions to natural systems on the well-being of life on Earth. Co-organized by Natura Artis Magistra (ARTIS) and the European Hub of the Planetary Health Alliance (PHA), the Congress featured five workshops: The Future of Planetary Health Cities, Impact through Synergy, Planetary Health Education, Movement Building, and Food and Microbes. Oral presentations addressed the theme of how human health and the health of human civilization depend on the natural environment, including subthemes on Earth, Water, and Food. Additionally, the subtheme of Humans reflected on how humanity can thrive within Planetary Boundaries and how to imagine a prosperous future for all life on Earth. The First European Planetary Health Congress offered a platform for fostering sustainable, just, and equitable societies within ecological limits. Accordingly, ARTIS and the European Hub aim to shape a hopeful future for generations to come.